Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nubeqa
Pharma
Bayer projects Xarelto's sales decline will gain steam in 2025
After Xarelto saw a sales decline of 600 million euros last year because of generic competition, Bayer is projecting a sharper fall in 2025.
Kevin Dunleavy
Mar 5, 2025 11:17am
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Jan 15, 2025 8:00pm
Bayer's 'transition year' looms as Xarelto sales falter
Nov 12, 2024 3:03pm
Bayer proposes Nubeqa chemo-free regimen in prostate cancer type
Sep 16, 2024 4:15am
Bayer charts growth course amid Xarelto's ongoing sales descent
Aug 6, 2024 12:29pm
Bayer clinches 2nd win for Nubeqa in prostate cancer subtype
Jul 17, 2024 9:42am
